1. Home
  2. HPQ vs WAT Comparison

HPQ vs WAT Comparison

Compare HPQ & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HP Inc.

HPQ

HP Inc.

HOLD

Current Price

$23.20

Market Cap

22.9B

Sector

Technology

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$374.13

Market Cap

22.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HPQ
WAT
Founded
1939
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
22.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HPQ
WAT
Price
$23.20
$374.13
Analyst Decision
Hold
Buy
Analyst Count
13
15
Target Price
$25.85
$390.67
AVG Volume (30 Days)
14.2M
559.4K
Earning Date
11-25-2025
11-04-2025
Dividend Yield
5.12%
N/A
EPS Growth
N/A
3.82
EPS
2.65
10.88
Revenue
$55,295,000,000.00
$3,105,638,000.00
Revenue This Year
$2.73
$7.96
Revenue Next Year
$1.39
$6.32
P/E Ratio
$8.85
$34.60
Revenue Growth
3.24
6.90
52 Week Low
$21.21
$275.05
52 Week High
$35.28
$423.56

Technical Indicators

Market Signals
Indicator
HPQ
WAT
Relative Strength Index (RSI) 35.13 43.63
Support Level $22.98 $372.93
Resistance Level $25.58 $397.55
Average True Range (ATR) 0.67 9.27
MACD -0.11 -4.08
Stochastic Oscillator 6.37 11.63

Price Performance

Historical Comparison
HPQ
WAT

About HPQ HP Inc.

HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: